ACLS Axcelis Technologies, Inc. - Fundamental Analysis
NEUTRAL
Sign in to save
Save this symbol to a watchlist or track a position.
ACLS Stock | Fundamental Analysis & Investment Insights
NASDAQ
Technology
Semiconductor Equipment & Materials
Current Price
Live
$94.55
Analyst Target
$96.33
+1.9%
Upside
52W High
$102.93
52W Low
$40.4
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Feb 14, 2026
Market cap
$2.93B
P/E
21.34
ROE
13.6%
Profit margin
15.9%
Debt/Equity
0.07
Dividend yield
N/A
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
82%
Analysis Accuracy
ACLS demonstrates strong financial health with a Piotroski F-Score of 8/9, indicating robust operational efficiency and profitability. The company's Graham Number of $57.27 suggests significant upside potential, though the current price of $94.55 trades at a premium, reflecting high growth expectations. Despite a recent 16.7% YoY revenue decline and 44.3% earnings drop, the firm has consistently beaten earnings estimates over the past four quarters with an average surprise of 83.7%, signaling strong execution. However, negative growth trends, bearish insider activity, and a lack of dividend yield limit near-term appeal. The sector context reveals elevated valuations, with the average P/E at 80.43, placing ACLS in a high-growth, high-risk environment.
Key Strengths
Piotroski F-Score of 8/9 indicates strong financial health and operational efficiency
Consistently beats earnings estimates with an average surprise of 83.7% over the last four quarters
Strong gross margin (44.67%) and solid operating margin (11.71%) reflect pricing power and cost control
Extremely low debt/equity (0.07) and high liquidity (current ratio 4.95) signal minimal financial risk
Historical earnings progression shows resilience and strong bottom-line performance despite cyclical headwinds
Key Risks
Significant YoY revenue and earnings declines (-16.7% and -44.3%) indicate deteriorating demand or market share erosion
Bearish insider sentiment with two recent sell transactions totaling $0.44M, signaling internal caution
Current price of $94.55 trades well above the Graham Number ($57.27) and intrinsic value ($31.01), implying high valuation premium
No analyst target price data available, reducing transparency on forward expectations despite a 'hold' recommendation
Negative Q/Q earnings growth (-46.5%) and lack of free cash flow data raise concerns about sustainability of profitability
AI Fair Value Estimate
Based on comprehensive analysis
$57.27
-39.4% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
54
Moderate
52
45
85
90
0
AI Verdict
neutral
Key drivers: High Piotroski F-Score and strong balance sheet, Persistent earnings beat history, Significant revenue and earnings contraction, Premium valuation relative to Graham Number, Bearish insider activity
Confidence
85%
Value
52/100
Ref P/E, PEG, Graham Number
Positives
- Graham Number of $57.27 provides a defensive floor
- Intrinsic value of $31.01 suggests undervaluation if growth resumes
Watchpoints
- Current price ($94.55) is 65% above Graham Number
- No PEG ratio available, but high P/E (21.34) suggests premium valuation
- Price/Sales of 3.44 is elevated relative to sector peers
Future
45/100
Ref Growth rates
Positives
- Strong earnings beat history suggests management capability
- Recent Q/Q EPS growth of +7.1% hints at stabilization
Watchpoints
- YoY revenue and earnings growth are sharply negative (-16.7% and -44.3%)
- Q/Q earnings growth is -46.5%, indicating worsening trends
- No forward guidance or PEG ratio to assess growth sustainability
Past
85/100
Ref Historical trends
Positives
- Piotroski F-Score of 8/9 reflects strong historical financial discipline
- Consistent earnings surprises (avg +83.7%) over last 4 quarters
- High ROE (13.62%) and ROA (6.40%) indicate efficient capital use
Watchpoints
- Declining revenue and earnings trends over the past year
- Historical growth has decelerated from prior cycles
Health
90/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Piotroski F-Score of 8/9 is in the 'strong' range
- Debt/Equity of 0.07 is near-zero, indicating minimal leverage
- Current ratio of 4.95 and quick ratio of 3.00 show exceptional liquidity
Watchpoints
- Altman Z-Score not available, but financial health is strong by other metrics
Dividend
0/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- No dividend yield or payout ratio
- Dividend Strength score of 0/100 indicates no income component
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$94.55
Analyst Target
$96.33
Upside/Downside
+1.9%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ACLS and closest competitors.
Updated 2026-02-13
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ACLS
Axcelis Technologies, Inc.
Primary
|
+133.8% | -25.8% | +52.5% | +17.4% | +1.4% | +9.8% |
|
AAOI
Applied Optoelectronics, Inc.
Peer
|
+246.5% | +1546.7% | +64.4% | +98.8% | +29.0% | +0.4% |
|
AMBA
Ambarella, Inc.
Peer
|
-46.0% | -34.2% | -19.1% | -1.4% | -9.8% | -0.6% |
|
BLKB
Blackbaud, Inc.
Peer
|
-14.3% | -11.3% | -26.1% | -13.8% | -11.1% | +1.6% |
|
AVPT
AvePoint, Inc.
Peer
|
-18.5% | +186.8% | -31.3% | -32.2% | -7.4% | -0.7% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
21.34
Forward P/E
21.53
PEG Ratio
N/A
P/B Ratio
2.87
P/S Ratio
3.44
EV/Revenue
2.99
EV/EBITDA
17.22
Market Cap
$2.93B
Profitability
Profit margins and return metrics
Profit Margin
15.93%
Operating Margin
11.71%
Gross Margin
44.67%
ROE
13.62%
ROA
6.4%
Growth
Revenue and earnings growth rates
Revenue Growth
-16.7%
Earnings Growth
-44.3%
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
-46.5%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.07
Low debt
Current Ratio
4.95
Strong
Quick Ratio
3.0
Excellent
Cash/Share
$14.5
Quarterly Earnings History
EPS performance vs analyst estimates
2026-02-17
$N/A
2025-11-04
$1.21
+20.6% surprise
2025-08-05
$1.13
+59.1% surprise
2025-05-06
$1.04
+171.3% surprise
Technology Sector Comparison
Comparing ACLS against 149 companies in the Technology sector
(11 bullish, 68 neutral, 70 bearish)
P/E Ratio
21.34
This Stock
vs
80.48
Sector Avg
-73.5%
(Discount)
Return on Equity (ROE)
13.62%
This Stock
vs
-6.46%
Sector Avg
-310.8%
(Below Avg)
Profit Margin
15.93%
This Stock
vs
-9.27%
Sector Avg
-271.9%
(Weaker)
Debt to Equity
0.07
This Stock
vs
0.7
Sector Avg
-89.8%
(Less Debt)
Revenue Growth
-16.7%
This Stock
vs
61.63%
Sector Avg
-127.1%
(Slower)
Current Ratio
4.95
This Stock
vs
3.39
Sector Avg
+45.7%
(Stronger)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ACLS
Axcelis Technologies, Inc.
|
NEUTRAL | $2.93B | 21.34 | 13.6% | 15.9% | $94.55 | |
|
AAOI
Applied Optoelectronics, Inc.
|
BEARISH | $3.04B | - | -40.4% | -37.0% | $44.46 | |
|
AMBA
Ambarella, Inc.
|
NEUTRAL | $2.74B | - | -13.9% | -21.3% | $63.64 | |
|
BLKB
Blackbaud, Inc.
|
BEARISH | $2.73B | - | -77.2% | -22.2% | $56.34 | |
|
AVPT
AvePoint, Inc.
|
NEUTRAL | $2.72B | - | 0.7% | 0.5% | $12.59 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-15 | MAHONEY ROBERT JOHN | Officer | Stock Award | 1,734 | - |
| 2025-12-17 | TITINGER JORGE LUIS | Director | Sale | 2,000 | $172,100 |
| 2025-12-11 | BLUMENSTOCK GERALD M | Officer | Sale | 3,034 | $271,422 |
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
HOLD
3 analysts
B. Riley Securities
2026-01-21
Neutral
Neutral
B of A Securities
2026-01-13
Underperform
Underperform
B. Riley Securities
2025-11-05
Neutral
Neutral
B of A Securities
2025-10-13
Neutral
Underperform
DA Davidson
2025-10-02
Buy
Buy
Benchmark
2025-10-02
Hold
Buy
Past News Coverage
Recent headlines mentioning ACLS from our newsroom.
Newest → oldest
No matching news yet.